Mylan N.V. (MYL) : Fridays money flow data in Mylan N.V. (MYL) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $140.88 million, whereas, $134.2 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.05, in favor of the bulls. The total money flow into the stock was $6.67 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $4.66 million. The total value of block trades done on upticks was $23.59 million. The value of bearish trades on downticks was only $18.94 million.The up/down ratio in the block trades was a healthy 1.25 in favor of the bulls, suggesting strong buying in the stock by large traders. Mylan N.V. (MYL) fell $1.95 and traded at $39.97, down -4.65% for the day, over previous days close. On a weekly basis, the shares are -7.11% over the previous weeks close.
The company Insiders own 0.71% of Mylan N.V. shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -10.79% . Institutional Investors own 60.48% of Mylan N.V. shares. During last six month period, the net percent change held by insiders has seen a change of -12.24%.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (Chief Executive Officer) of Mylan N.V., Bresch Heather M had sold 100,200 shares worth of $5,010,000 in a transaction dated August 9, 2016. In this transaction, 100,200 shares were sold at $50 per share.
Mylan N.V. (NASDAQ:MYL): stock was range-bound between the intraday low of $39.82 and the intraday high of $42.09 after having opened at $42.01 on Fridays session. The stock finally closed in the red at $42.01, a loss of -4.65%. The stock remained in the red for the whole trading day. The total traded volume was 17,238,016 shares. The stock failed to cross $42.09 in Fridays trading. The stocks closing price on Thursday was $41.92.
Mylan N.V. (MYL) : During the past 4 weeks, traders have been relatively bearish on Mylan N.V. (MYL), hence the stock is down -17.41% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -7.58% relative to the S&P 500. The 4-week change in the price of the stock is -17.52% and the stock has fallen -7.11% in the past 1 week.
Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. The Companys generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its specialty pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). The Companys API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. Mylan provides products to customers in approximately 140 countries and territories.